DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT03297879

CompletedPhase 4

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes

Beijing Chao-Yang Hospital, Capital Medical University

Asset

Exenatide

GLP-1 agonist

Listed sites

0

Recruiting sites

—

Enrollment

230

actual

Study population

Obesity / overweight, Type 2 diabetes

Key I/E criteria

•BMI ≥24•HbA1c ≥7%

Primary endpoint

•HbA1c, change

Identifiers

Registered as

NCT IDNCT03297879
Org study ID2015-科 144

Timeline

Milestones

Study start2013-01-01actual
Primary completion2016-02-28actual
Study completion2016-02-28actual
Study first posted2017-09-29actual
Last update posted2017-10-02actual

Assets

Investigational agents

Exenatide

Study populations

Who this study enrolls

Obesity / overweightType 2 diabetes

Eligibility

Who can enroll

Minimum age20 Years
Maximum age65 Years
SexAll
Healthy volunteersNot accepted

Inclusion criteria

•age 20 - <65 years,
•body mass index (BMI) ≥ 24 kg/m2,
•HbA1c ≥ 7% (53mmol/mol).
•diabetes antibodies (-)
•diagnosed with T2D within the previous 3 months

Exclusion criteria

•anti-diabetic drugs or diet therapy before participation
•pancreatitis
•coronary artery disease
•liver function impairment
•renal function impairment
•intestinal surgery
•chronic hypoxic diseases (emphysema and cor pulmonale)
•infectious disease
•hematological disease
•systemic inflammatory disease
•cancer
•pregnant, possibly pregnant
•ingesting agents known to influence glucose or lipid metabolism

Endpoints (1)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Glycemic / diabetes

1 endpoint
Primary/protocol endpoint

The change of HbA1c

Time frame:baseline and 12 weeks

HbA1c, change

change from baseline, improvement

LOINC 4548-4

Publications (2)

Bibliography

Records linked to this trial through ClinicalTrials.gov references, PubMed NCT search, and curated study seeds. 'Canonical' marks design/result papers; others are registry references or candidates.

Registry references + supporting bibliography

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.